English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Bladder cancer is the ninth most prevalent cancer in the world and most common malignancy involving the urinary system with 430 000 cases diagnosed in 2012.(1) Urothelial cell carcinoma (UCC, also known as transitional cell carcinoma) is considered to be the predominant histological type of bladder cancer in the United States and Western Europe. While greater than 50% of UCC cases are non-muscle invasive with relatively good prognosis, soft tissue invasion and metastatic spread offer much worse outcomes.(2) The most common areas for metastatic spread of UCC are the lymph nodes, bones, lung, and liver. Advanced UCC has a poor prognosis with an overall five year survival of less than 15%.(3) Recent reports of the distribution of UCC metastases from clinical sites found evidence of soft tissue metastases, however these occurred in the presence of advanced stage disease with lesions present in additional locations of the body.(4, 5) UCC metastases to soft tissue in the absence of disease elsewhere in the body are exceedingly rare and few cases are described. We present the rare case of a 70-year-old patient with metastases to the soft tissue of the arm without other sites of recurrence, six months after radical cystoprostatectomy for muscle invasive UCC of the bladder.

Images – Isolated forearm soft tissue metastasis from bladder cancer